WB
RXRX icon

WesBanco Bank’s Recursion Pharmaceuticals RXRX Stock Holding History

WesBanco Bank’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-112,517
Closed -$595K – 661
2025
Q1 		$595K Hold
112,517
– – 0.02% 401
2024
Q4 		$761K Buy
112,517
+1,317
+1% +$8.86K 0.03% 355
2024
Q3 		$733K Hold
111,200
– – 0.02% 372
2024
Q2 		$834K Buy
111,200
+46,000
+71% +$401K 0.03% 330
2024
Q1 		$650K Buy
+65,200
New +$726K 0.02% 374

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

WesBanco Bank's RXRX Position: Q2 2025 in Review

WesBanco Bank sold out of Recursion Pharmaceuticals (RXRX) in Q2 2025, closing a stake of 112,517 shares — an estimated $595K sold.

WesBanco Bank first reported a position in RXRX in Q1 2024 and held it in 5 quarters. The position peaked at $834K in Q2 2024. 332 funds tracked by Wall St. Rank hold RXRX as of Q2 2025.

  • WesBanco Bank reported no remaining Recursion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • WesBanco Bank sold 112,517 Recursion Pharmaceuticals shares in Q2 2025, an estimated $595K.
  • WesBanco Bank first reported a position in Recursion Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • WesBanco Bank's Recursion Pharmaceuticals position peaked at $834K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2025.

Based on WesBanco Bank's 13F filing for Q2 2025, filed 7 Jul 2025.